Evaluation of Amyloid Polypeptide Aggregation Inhibition and Disaggregation Activity of A-Type Procyanidins
The number of people worldwide suffering from Alzheimer’s disease (AD) and type 2 diabetes (T2D) is on the rise. Amyloid polypeptides are thought to be associated with the onset of both diseases. Amyloid-β (Aβ) that aggregates in the brain and human islet amyloid polypeptide (hIAPP) that aggregates...
Guardado en:
Autores principales: | Taisei Tanaka, Vipul V. Betkekar, Ken Ohmori, Keisuke Suzuki, Hideyuki Shigemori |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7773d17386fd4013be31a8374bb06bd0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus
por: Jeong HR, et al.
Publicado: (2015) -
Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes
por: Anne-Cathrine S. Vogt, et al.
Publicado: (2021) -
Phenolic composition, antioxidant activity, anticholinesterase potential and modulatory effects of aqueous extracts of some seaweeds on β-amyloid aggregation and disaggregation
por: Tosin A. Olasehinde, et al.
Publicado: (2019) -
Human Islet Amyloid Polypeptide Overexpression in INS-1E Cells Influences Amylin Oligomerization under ER Stress and Oxidative Stress
por: Yeong-Min Yoo, et al.
Publicado: (2021) -
Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies
por: Brittany S. Bruggeman, et al.
Publicado: (2021)